These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8667087)
1. Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity. Als C; Rösler H; Kinser JA J Nucl Med; 1996 Feb; 37(2):401-3. PubMed ID: 8667087 [No Abstract] [Full Text] [Related]
2. Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity. Clerc J; Dagousset F; Izembart M; Jais JP; Heshmati HM; Alcaïs A; Chevalier A; Léger AF; Barritault L J Nucl Med; 1995 Feb; 36(2):217-23. PubMed ID: 7830117 [TBL] [Abstract][Full Text] [Related]
3. Dosimetry study in patients with autonomous thyroid nodule who are candidates for radioiodine therapy. Reschini E; Matheoud R; Canzi C; Castellani M; Galelli M; Ferrari C; Paracchi A; Gerundini P J Nucl Med; 1999 Nov; 40(11):1928-34. PubMed ID: 10565791 [TBL] [Abstract][Full Text] [Related]
4. Thyrotoxicosis due to ectopic retrotracheal adenoma treated with radioiodine. Salvatori M; Rufini V; Corsello SM; Saletnich I; Rota CA; Barbarino A; Troncone L J Nucl Biol Med (1991); 1993 Jun; 37(2):69-72. PubMed ID: 8373835 [TBL] [Abstract][Full Text] [Related]
5. [Immunogenic hyperthyroidism following radioiodine ablation of a focal autonomy]. Boddenberg B; Voth E; Schicha H Nuklearmedizin; 1993 Feb; 32(1):18-22. PubMed ID: 8464755 [TBL] [Abstract][Full Text] [Related]
6. [Effect of iodine application during radioiodine therapy in patients with impending therapy failure]. Urbannek V; Schmidt M; Moka D; Hillger HW; Voth E; Wellner U; Schicha H Nuklearmedizin; 2000; 39(4):108-12. PubMed ID: 10919161 [TBL] [Abstract][Full Text] [Related]
7. An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule. Amato E; Lizio D; Ruggeri RM; Raniolo M; Campennì A; Baldari S Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):560-6. PubMed ID: 21242948 [TBL] [Abstract][Full Text] [Related]
8. Radioiodine therapy of thyroid autonomy. Reiners C; Schneider P Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548 [TBL] [Abstract][Full Text] [Related]
9. [Changes in thyroid volume after radioactive iodine therapy in patients with single toxic thyroid nodule]. Gołkowski F; Jabrocka-Hybel A; Huszno B Przegl Lek; 2005; 62(5):284-6. PubMed ID: 16334533 [TBL] [Abstract][Full Text] [Related]
10. DNA damage and its repair in lymphocytes and thyroid nodule cells during radioiodine therapy in patients with hyperthyroidism. Grzesiuk W; Nieminuszczy J; Kruszewski M; Iwanienko T; Plazinska M; Bogdanska M; Bar-Andziak E; Królicki L; Grzesiuk E J Mol Endocrinol; 2006 Dec; 37(3):527-32. PubMed ID: 17170092 [TBL] [Abstract][Full Text] [Related]
11. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study. Ceccarelli C; Bencivelli W; Vitti P; Grasso L; Pinchera A Clin Endocrinol (Oxf); 2005 Mar; 62(3):331-5. PubMed ID: 15730415 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic efficiency of iodine 131 in autonomous thyroid adenoma and toxic multinodular goiter. Apropos of 59 cases]. Guermazi F; Fekih MA; Kraiem A; Mtimet S Ann Endocrinol (Paris); 1991; 52(5):323-6. PubMed ID: 1819221 [TBL] [Abstract][Full Text] [Related]
13. Tissue-specific dosimetry for radioiodine therapy of the autonomous thyroid nodule. Matheoud R; Canzi C; Reschini E; Zito F; Voltini F; Gerundini P Med Phys; 2003 May; 30(5):791-8. PubMed ID: 12772986 [TBL] [Abstract][Full Text] [Related]
14. Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 years? Shapiro B J Nucl Med; 1993 Oct; 34(10):1638-41. PubMed ID: 8410274 [No Abstract] [Full Text] [Related]
15. The relationship between 24 h/4 h radioiodine-131 uptake ratio and outcome after radioiodine therapy in 1402 patients with solitary autonomously functioning thyroid nodules. Filesi M; Travascio L; Montesano T; Di Nicola AD; Colandrea M; Ugolini F; Bruno R; Gross MD; Vestri A; Rubello D; Ronga G Ann Nucl Med; 2009 May; 23(3):229-34. PubMed ID: 19322512 [TBL] [Abstract][Full Text] [Related]
16. Influence of various geometric factors on the iodine-131 uptake measurement for solitary thyroid nodules. Jentzen W; Görges R; Freudenberg L; Eising EG; Müller SP; Bockisch A Nucl Med Commun; 2008 Apr; 29(4):398-404. PubMed ID: 18317306 [TBL] [Abstract][Full Text] [Related]
17. [Radiometabolic therapy of the autonomous thyroid nodule]. Mariotti S; Caturegli P; Barbesino G; Ceccarelli C; Lippi F; Marinò M; Manetti L; Martino E; Pinchera A Minerva Endocrinol; 1993 Dec; 18(4):155-63. PubMed ID: 8190055 [TBL] [Abstract][Full Text] [Related]
18. Effect of radioiodine therapy on thyroid nodule size and function in patients with toxic adenomas. Erdoğan MF; Küçük NO; Anil C; Aras S; Ozer D; Aras G; Kamel N Nucl Med Commun; 2004 Nov; 25(11):1083-7. PubMed ID: 15577585 [TBL] [Abstract][Full Text] [Related]
19. Thyrotoxicosis: changing trends in treatment. Sheldon J; Reid DJ Ann R Coll Surg Engl; 1986 Sep; 68(5):283-5. PubMed ID: 3789627 [TBL] [Abstract][Full Text] [Related]
20. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Døssing H; Bennedbaek FN; Bonnema SJ; Grupe P; Hegedüs L Eur J Endocrinol; 2007 Jul; 157(1):95-100. PubMed ID: 17609407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]